-
Trends and Scope of Japan’s Across-the-Board Pharmaceutical Price Revisions in FY2021-25
Sep 9, 2025, 16:22 PM -
Systematic Literature Review on the Burden and Economic Impact of Invasive Meningococcal Disease in Adolescents and Young Adults in France, Italy, Spain, and Germany
Sep 9, 2025, 16:22 PM -
Economic Burden of COPD in Algeria: A Retrospective Analysis of Healthcare Resource Utilization and Costs
Sep 9, 2025, 16:22 PM -
The Incidence and Survival of HPV-Positive and HPV-Negative Malignant Head and Neck Squamous Cell Carcinoma (HNSCC) in the United States: A Surveillance Epidemiology and End Results SEER 2000-2022 Database Analysis
Sep 9, 2025, 16:22 PM -
Regulatory Approval and Economic Evaluation of Tumor-Agnostic Therapies: A Comparative Study of Larotrectinib and Entrectinib
Sep 9, 2025, 16:22 PM -
Modeled Number and Cost of Biparametric Magnetic Resonance Imaging (bpMRI) Examinations in a Nationwide Prostate Cancer Screening Program: Utilizing the Results of the Czech Prostapilot Study
Sep 9, 2025, 16:22 PM -
Cost of Adverse Events With the Bruton Tyrosine Kinase Inhibitors Ibrutinib and Acalabrutinib in the First-Line Treatment of Chronic Lymphocytic Leukemia in Brazil
Sep 9, 2025, 16:22 PM -
A Patient-Level Simulation to Bridge Data Gaps in Cost-Effectiveness Modeling of B-VEC for Dystrophic Epidermolysis Bullosa
Sep 9, 2025, 16:22 PM -
Drivers of Inpatient Costs in Oncology Patients Undergoing Major Abdominal Surgery: Evidence from a Middle-Income Country
Sep 9, 2025, 16:22 PM -
Looking Back to Go Forward: Reintegrating Scientific Considerations Into eCOA Design and Implementation
Sep 9, 2025, 16:22 PM -
Association Between Invasive Disease-Free Survival/Distant Recurrence-Free Survival and Overall Survival in Patients With Early Stage Triple-Negative Breast Cancer
Sep 9, 2025, 16:22 PM -
Value of Patient-Reported Outcomes Data in Food and Drug Administration Labeling of Oncology Drugs to Payers in the United States
Sep 9, 2025, 16:22 PM -
Recognizing the Full Value of Novel Antibiotics: Identifying Value Elements in the Context of Antimicrobial Resistance
Sep 9, 2025, 16:22 PM -
Dupilumab Improves Lung Function and Asthma Control While Reducing Systemic Corticosteroid Use in Patients With Allergic Bronchopulmonary Aspergillosis: The Phase 2 LIBERTY ABPA AIRED Study
Sep 9, 2025, 16:22 PM -
Decluttering Complexity: A Pragmatic Framework for Simplifying Global Health Economic Models for HTA
Sep 9, 2025, 16:22 PM -
Protocol for a Health Preference Study on Digital Health Interventions: Integrating DCE and BWS to Capture Subject, Interaction, System, and Societal Value
Sep 9, 2025, 16:22 PM -
Qualitative Insights Into Artificial Intelligence (AI) and Virtual Reality (VR) Training for Value Communication: Comparing Innovative Technologies With Traditional Methods in Pharma
Sep 9, 2025, 16:22 PM -
Early Change in Proteinuria as a Surrogate Endpoint in Studies of IgA Nephropathy: An Updated Patient-Level Meta-Analysis and Discussion of Appropriate Methodology
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole for the Treatment of Invasive Aspergillosis in Morocco
Sep 9, 2025, 16:22 PM -
Are We Getting Good Value for Innovative Therapies in the US? Findings From Generalized Cost-Effectiveness Analyses (GCEAs)
Sep 9, 2025, 16:22 PM
